| Authors: |
Bernardino RM; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. ruimmbernardino@gmail.com.; Computational and Experimental Biology Group, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal. ruimmbernardino@gmail.com., Yin LB; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Lajkosz K; Department of Statistics, Princess Margaret Cancer Center, Toronto, ON, Canada., Cockburn JG; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Wettstein M; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Sayyid RK; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Henrique R; Department of Pathology and Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP @RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre Raquel Seruca (Porto.CCC Raquel Seruca), R. Dr. António Bernardino de Almeida, Porto, Portugal., Pinheiro LC; Department Urology, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal., van der Kwast T; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Fleshner NE; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. |
